Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2011-06-29

FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA records a supplemental application for VIIBRYD (vilazodone hydrochloride) filed by Allergan, Inc., likely seeking changes to the labeling. Vilazodone is an …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viibryd (vilazodone)

Snippet

SUPPL AP for VIIBRYD (VILAZODONE HYDROCHLORIDE)